631 related articles for article (PubMed ID: 4024100)
1. The metabolism of di(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism.
Lhuguenot JC; Mitchell AM; Milner G; Lock EA; Elcombe CR
Toxicol Appl Pharmacol; 1985 Aug; 80(1):11-22. PubMed ID: 4024100
[TBL] [Abstract][Full Text] [Related]
2. Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl) phthalate.
Mitchell AM; Lhuguenot JC; Bridges JW; Elcombe CR
Toxicol Appl Pharmacol; 1985 Aug; 80(1):23-32. PubMed ID: 4024105
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of mono-(2-ethylhexyl) phthalate (MEHP) and liver peroxisome proliferation in the hamster.
Lhuguenot JC; Mitchell AM; Elcombe CR
Toxicol Ind Health; 1988 Dec; 4(4):431-41. PubMed ID: 3188042
[TBL] [Abstract][Full Text] [Related]
4. Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate in primary hepatocyte cultures derived from rat, guinea pig, rabbit and monkey. Relationship between interspecies differences in biotransformation and peroxisome proliferating potencies.
Dirven HA; van den Broek PH; Peeters MC; Peters JG; Mennes WC; Blaauboer BJ; Noordhoek J; Jongeneelen FJ
Biochem Pharmacol; 1993 Jun; 45(12):2425-34. PubMed ID: 8328980
[TBL] [Abstract][Full Text] [Related]
5. Effects of di-(2-ethylhexyl) phthalate and five of its metabolites on rat testis in vivo and in in vitro.
Sjöberg P; Bondesson U; Gray TJ; Plöen L
Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):225-33. PubMed ID: 3716815
[TBL] [Abstract][Full Text] [Related]
6. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
Koch HM; Bolt HM; Preuss R; Angerer J
Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144
[TBL] [Abstract][Full Text] [Related]
7. Non-linearities in the pharmacokinetics of di-(2-ethylhexyl) phthalate and metabolites in male rats.
Sjöberg P; Bondesson U; Hammarlund M
Arch Toxicol; 1985 Dec; 58(2):72-7. PubMed ID: 4091659
[TBL] [Abstract][Full Text] [Related]
8. Determination of four metabolites of the plasticizer di(2-ethylhexyl)phthalate in human urine samples.
Dirven HA; van den Broek PH; Jongeneelen FJ
Int Arch Occup Environ Health; 1993; 64(8):555-60. PubMed ID: 8314613
[TBL] [Abstract][Full Text] [Related]
9. Disposition of orally administered di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate in the rat.
Teirlynck OA; Belpaire F
Arch Toxicol; 1985 Sep; 57(4):226-30. PubMed ID: 4091646
[TBL] [Abstract][Full Text] [Related]
10. Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver.
Isenberg JS; Kamendulis LM; Smith JH; Ackley DC; Pugh G; Lington AW; Klaunig JE
Toxicol Sci; 2000 Jul; 56(1):73-85. PubMed ID: 10869455
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms.
Elcombe CR; Mitchell AM
Environ Health Perspect; 1986 Dec; 70():211-9. PubMed ID: 3104023
[TBL] [Abstract][Full Text] [Related]
12. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate.
Kato K; Silva MJ; Reidy JA; Hurtz D; Malek NA; Needham LL; Nakazawa H; Barr DB; Calafat AM
Environ Health Perspect; 2004 Mar; 112(3):327-30. PubMed ID: 14998748
[TBL] [Abstract][Full Text] [Related]
13. Effects of route of administration and repetitive dosing on the disposition kinetics of di(2-ethylhexyl) phthalate and its mono-de-esterified metabolite in rats.
Pollack GM; Li RC; Ermer JC; Shen DD
Toxicol Appl Pharmacol; 1985 Jun; 79(2):246-56. PubMed ID: 4002226
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP.
Kessler W; Numtip W; Völkel W; Seckin E; Csanády GA; Pütz C; Klein D; Fromme H; Filser JG
Toxicol Appl Pharmacol; 2012 Oct; 264(2):284-91. PubMed ID: 22963843
[TBL] [Abstract][Full Text] [Related]
15. In vitro metabolism of di(2-ethylhexyl) phthalate (DEHP) by various tissues and cytochrome P450s of human and rat.
Choi K; Joo H; Campbell JL; Clewell RA; Andersen ME; Clewell HJ
Toxicol In Vitro; 2012 Mar; 26(2):315-22. PubMed ID: 22186153
[TBL] [Abstract][Full Text] [Related]
16. Endocrine disruption: In silico perspectives of interactions of di-(2-ethylhexyl)phthalate and its five major metabolites with progesterone receptor.
Sheikh IA; Abu-Elmagd M; Turki RF; Damanhouri GA; Beg MA; Al-Qahtani M
BMC Struct Biol; 2016 Sep; 16(Suppl 1):16. PubMed ID: 27719669
[TBL] [Abstract][Full Text] [Related]
17. Mono-2-ethylhexyl phthalate, a metabolite of di-(2-ethylhexyl) phthalate, causally linked to testicular atrophy in rats.
Albro PW; Chapin RE; Corbett JT; Schroeder J; Phelps JL
Toxicol Appl Pharmacol; 1989 Sep; 100(2):193-200. PubMed ID: 2781553
[TBL] [Abstract][Full Text] [Related]
18. Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets.
Kessler W; Numtip W; Grote K; Csanády GA; Chahoud I; Filser JG
Toxicol Appl Pharmacol; 2004 Mar; 195(2):142-53. PubMed ID: 14998681
[TBL] [Abstract][Full Text] [Related]
19. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
Barr DB; Silva MJ; Kato K; Reidy JA; Malek NA; Hurtz D; Sadowski M; Needham LL; Calafat AM
Environ Health Perspect; 2003 Jul; 111(9):1148-51. PubMed ID: 12842765
[TBL] [Abstract][Full Text] [Related]
20. Urinary and amniotic fluid levels of phthalate monoesters in rats after the oral administration of di(2-ethylhexyl) phthalate and di-n-butyl phthalate.
Calafat AM; Brock JW; Silva MJ; Gray LE; Reidy JA; Barr DB; Needham LL
Toxicology; 2006 Jan; 217(1):22-30. PubMed ID: 16171919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
